Comparative efficacy of prophylactic monoclonal (OKT3) and polyclonal antibodies (ATG) in immunologic high-risk renal transplant recipients.
作者信息
Fukuuchi F, Lefrançois N, Chapuis F, Gebuhrer L, Bosshard S, Dubernard J M, Touraine J L
机构信息
Unit of transplantation, Hôpital Edouard Herriot, Lyon, France.
出版信息
Transplant Proc. 1996 Oct;28(5):2808-9.
PMID:8908070
Abstract
摘要
相似文献
1
2
Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation?在尸体肾移植中常规使用抗淋巴细胞球蛋白（ALG）或OKT3进行诱导免疫抑制是否合理？
Transplant Proc. 1993 Feb;25(1 Pt 1):575-6.
3
Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.肾移植中OKT3与抗胸腺细胞球蛋白作为诱导免疫抑制剂的比较。
Transplant Proc. 1996 Jun;28(3):1973-5.
4
Late acute rejection in renal transplant recipients: response to steroid treatment.
Transplant Proc. 1992 Feb;24(1):35-6.
5
Optimization of cyclosporine monotherapy--long-term graft function.
Transplant Proc. 1994 Oct;26(5):2501-6.
6
Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.采用短疗程抗体疗法治疗类固醇抵抗型和复发性急性心脏移植排斥反应。
Clin Transplant. 1997 Aug;11(4):316-21.
7
Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.更昔洛韦治疗肾移植受者巨细胞病毒感染
Transplant Proc. 1992 Oct;24(5):1921-3.
8
Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
Transplant Proc. 1992 Feb;24(1):39-41.
9
Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Transplant Proc. 1996 Aug;28(4):2136-7.
10
Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.免疫抑制疗法对肾移植受者感染并发症的影响。
Transplant Proc. 1992 Feb;24(1):292-4.
引用本文的文献
1
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
Zotero 插件